NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.
Publication
, Journal Article
Hoppe, RT; Advani, RH; Ai, WZ; Ambinder, RF; Aoun, P; Armand, P; Bello, CM; Benitez, CM; Bierman, PJ; Chen, R; Dabaja, B; Dean, R; Forero, A ...
Published in: J Natl Compr Canc Netw
March 2018
The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN Guidelines Panel meets at least annually to review comments from reviewers within the NCCN Member Institutions, examine relevant data, and reevaluate and update the recommendations. These NCCN Guidelines Insights summarize recent updates centered on treatment considerations for relapsed/refractory classic HL.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
March 2018
Volume
16
Issue
3
Start / End Page
245 / 254
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Humans
- Hodgkin Disease
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Aoun, P., Armand, P., … Ogba, N. (2018). NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018. J Natl Compr Canc Netw, 16(3), 245–254. https://doi.org/10.6004/jnccn.2018.0013
Hoppe, Richard T., Ranjana H. Advani, Weiyun Z. Ai, Richard F. Ambinder, Patricia Aoun, Philippe Armand, Celeste M. Bello, et al. “NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.” J Natl Compr Canc Netw 16, no. 3 (March 2018): 245–54. https://doi.org/10.6004/jnccn.2018.0013.
Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Armand P, et al. NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018. J Natl Compr Canc Netw. 2018 Mar;16(3):245–54.
Hoppe, Richard T., et al. “NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.” J Natl Compr Canc Netw, vol. 16, no. 3, Mar. 2018, pp. 245–54. Pubmed, doi:10.6004/jnccn.2018.0013.
Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Armand P, Bello CM, Benitez CM, Bierman PJ, Chen R, Dabaja B, Dean R, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maddocks K, Maloney DG, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Rabinovitch R, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N. NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018. J Natl Compr Canc Netw. 2018 Mar;16(3):245–254.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
March 2018
Volume
16
Issue
3
Start / End Page
245 / 254
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Humans
- Hodgkin Disease
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis